These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 32527282)
1. A European field assessment of the efficacy of fluralaner (Bravecto Petersen I; Chiummo R; Zschiesche E; Karas-Tecza J; Rapti D; Roepke R; Thomas E Parasit Vectors; 2020 Jun; 13(1):304. PubMed ID: 32527282 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis. Fourie JJ; Meyer L; Thomas E Parasit Vectors; 2019 Jan; 12(1):59. PubMed ID: 30683143 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation. Djuric M; Milcic Matic N; Davitkov D; Glavinic U; Davitkov D; Vejnovic B; Stanimirovic Z Parasit Vectors; 2019 May; 12(1):270. PubMed ID: 31138280 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs. Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320 [TBL] [Abstract][Full Text] [Related]
6. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes. Paterson TE; Halliwell RE; Fields PJ; Louw ML; Ball G; Louw J; Pinckney R Vet Parasitol; 2014 Oct; 205(3-4):687-96. PubMed ID: 25262617 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe. Lebon W; Beccati M; Bourdeau P; Brement T; Bruet V; Cekiera A; Crosaz O; Darmon C; Guillot J; Mosca M; Pin D; Popiel J; Pomorska Handwerker D; Larsen D; Tielemans E; Beugnet F; Halos L Parasit Vectors; 2018 Sep; 11(1):506. PubMed ID: 30201031 [TBL] [Abstract][Full Text] [Related]
8. A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalized demodicosis. Duangkaew L; Larsuprom L; Anukkul P; Lekcharoensuk C; Chen C Vet Dermatol; 2018 Jun; 29(3):208-e74. PubMed ID: 29424108 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of orally and topically administered fluralaner (Bravecto Chiummo R; Petersen I; Plehn C; Zschiesche E; Roepke R; Thomas E Parasit Vectors; 2020 Oct; 13(1):524. PubMed ID: 33069261 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats. Taenzler J; de Vos C; Roepke RK; Frénais R; Heckeroth AR Parasit Vectors; 2017 Jan; 10(1):30. PubMed ID: 28093080 [TBL] [Abstract][Full Text] [Related]
11. Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis. Perego R; Spada E; Foppa C; Proverbio D BMC Vet Res; 2019 Jan; 15(1):17. PubMed ID: 30616591 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and duration of action of oral fluralaner and spot-on moxidectin/imidacloprid in cats infested with Lynxacarus radovskyi. Han HS; Noli C; Cena T Vet Dermatol; 2016 Dec; 27(6):474-e127. PubMed ID: 27870235 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis. Six RH; Becskei C; Mazaleski MM; Fourie JJ; Mahabir SP; Myers MR; Slootmans N Vet Parasitol; 2016 May; 222():62-6. PubMed ID: 26971196 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. Beugnet F; Halos L; Larsen D; de Vos C Parasite; 2016; 23():14. PubMed ID: 27012161 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats. Taenzler J; de Vos C; Roepke RKA; Heckeroth AR Parasit Vectors; 2018 Nov; 11(1):595. PubMed ID: 30449272 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of lotilaner (Credelio™), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp. Snyder DE; Wiseman S; Liebenberg JE Parasit Vectors; 2017 Nov; 10(1):532. PubMed ID: 29089049 [TBL] [Abstract][Full Text] [Related]
17. Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid. Huang HP; Lien YH Acta Vet Scand; 2013 May; 55(1):40. PubMed ID: 23663380 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study. Becskei C; Cuppens O; Mahabir SP Vet Dermatol; 2018 Jun; 29(3):203-e72. PubMed ID: 29423956 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study. Heine J; Krieger K; Dumont P; Hellmann K Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs. Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]